Although disputed claims represent less than 3.5% of lifetime originations, one lawsuit for every 15 active borrowers highlights the legal and administrative costs of enforcing unsecured loans in high-inflation markets.
The Japanese development agency is stepping beyond traditional grants, joining VCs and corporate giants to finance the expansion of a Ghanaian "phygital" healthcare provider.
Simon Hazell returns to the CEO seat at Bioshroom, betting on high-margin wellness over commodity protein after energy crises and strategic missteps shuttered his previous agritech venture.
iProcure, once a darling of the agritech scene with over $17m in total funding — including a $10.2m Series B in 2022 — collapsed into administration in May 2024.
The acquisition marks a significant liquidity event for the East African ecosystem, offering a strategic entry point for bolttech's expansion into the continent.
Although disputed claims represent less than 3.5% of lifetime originations, one lawsuit for every 15 active borrowers highlights the legal and administrative costs of enforcing unsecured loans in high-inflation markets.
